Immunic, Inc.
IMUX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$100,507 | -$93,612 | -$120,407 | -$92,945 |
| Dep. & Amort. | $134 | $111 | $77 | $85 |
| Deferred Tax | $0 | $0 | $0 | $4,332 |
| Stock-Based Comp. | $8,527 | $7,102 | $7,929 | $5,949 |
| Change in WC | $564 | $15,048 | $9,530 | -$9,279 |
| Other Non-Cash | $6,516 | $523 | $37,727 | $8,625 |
| Operating Cash Flow | -$84,766 | -$70,828 | -$65,144 | -$83,233 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$264 | -$334 | -$112 | -$67 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$9,629 | $0 |
| Inv. Sales/Matur. | $0 | $9,796 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$264 | $9,462 | -$9,741 | -$67 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $74,273 | $0 | $0 | $0 |
| Stock Issued | $191 | $853 | $39,584 | $42,749 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $77 | $180 | $56,176 | $92 |
| Financing Cash Flow | $74,541 | $1,033 | $95,760 | $42,841 |
| Forex Effect | -$517 | $262 | -$993 | -$130 |
| Net Chg. in Cash | -$11,006 | -$60,071 | $19,882 | -$40,589 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $46,674 | $106,745 | $86,863 | $127,452 |
| End Cash | $35,668 | $46,674 | $106,745 | $86,863 |
| Free Cash Flow | -$85,030 | -$71,162 | -$65,256 | -$83,300 |